These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35925866)

  • 1. AAV-mediated gene-replacement therapy restores viability of BCD patient iPSC derived RPE cells and vision of Cyp4v3 knockout mice.
    Jia R; Meng X; Chen S; Zhang F; Du J; Liu X; Yang L
    Hum Mol Genet; 2023 Jan; 32(1):122-138. PubMed ID: 35925866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the role of ferroptosis in Bietti crystalline dystrophy and potential therapeutic strategies.
    Shen C; Yang Q; Chen K; Ma H; Wang X; Tong J; Shen Y; Cui H
    Cell Commun Signal; 2024 Jul; 22(1):359. PubMed ID: 38992691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti's Crystalline Dystrophy.
    Zhang Z; Yan B; Gao F; Li Q; Meng X; Chen P; Zhou L; Deng W; Li C; Xu W; Han S; Feng H; Li Y; Chen J; Yin Z; Liao C; Tse HF; Xu A; Lian Q
    Mol Ther; 2020 Dec; 28(12):2642-2661. PubMed ID: 32755565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo genome editing via CRISPR/Cas9-mediated homology-independent targeted integration for Bietti crystalline corneoretinal dystrophy treatment.
    Meng X; Jia R; Zhao X; Zhang F; Chen S; Yu S; Liu X; Dou H; Feng X; Zhang J; Wang N; Xu B; Yang L
    Nat Commun; 2024 May; 15(1):3773. PubMed ID: 38710738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating precision medicine approaches for gene therapy in patient-specific cellular models of Bietti crystalline dystrophy.
    Li Y; Yang RR; Li YS; Hsu CW; Jenny LA; Kong Y; Ruan MZ; Sparrow JR; Tsang SH
    JCI Insight; 2024 Aug; 9(16):. PubMed ID: 39171529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes.
    Hata M; Ikeda HO; Iwai S; Iida Y; Gotoh N; Asaka I; Ikeda K; Isobe Y; Hori A; Nakagawa S; Yamato S; Arita M; Yoshimura N; Tsujikawa A
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3936-3941. PubMed ID: 29581279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of Lipid Droplets in a Novel Bietti Crystalline Dystrophy Zebrafish Model With Impaired PPARα Pathway.
    Gao P; Jia D; Li P; Huang Y; Hu H; Sun K; Lv Y; Chen X; Han Y; Zhang Z; Ren X; Wang Q; Liu F; Tang Z; Liu M
    Invest Ophthalmol Vis Sci; 2022 May; 63(5):32. PubMed ID: 35616930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV2-mediated gene therapy for Bietti crystalline dystrophy provides functional CYP4V2 in multiple relevant cell models.
    Wang JH; Lidgerwood GE; Daniszewski M; Hu ML; Roberts GE; Wong RCB; Hung SSC; McClements ME; Hewitt AW; Pébay A; Hickey DG; Edwards TL
    Sci Rep; 2022 Jun; 12(1):9525. PubMed ID: 35680963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of CYP4V2 mutation in 36 Chinese families with Bietti crystalline corneoretinal dystrophy.
    Yin X; Yang L; Chen N; Cui H; Zhao L; Feng L; Li A; Zhang H; Ma Z; Li G
    Exp Eye Res; 2016 May; 146():154-162. PubMed ID: 26971461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy.
    Shan M; Dong B; Zhao X; Wang J; Li G; Yang Y; Li Y
    Mol Vis; 2005 Sep; 11():738-43. PubMed ID: 16179904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in the CYP4V2 gene in a Chinese patient with Bietti's crystalline dystrophy.
    Song Y; Mo G; Yin G
    Int Ophthalmol; 2013 Jun; 33(3):269-76. PubMed ID: 23242590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human induced pluripotent stem cell line from a Bietti crystalline corneoretinal dystrophy patient with CYP4V2 mutations.
    Wu S; Zhu T; Sun Z; Wei X; Han X; Zou X; Sui R
    Stem Cell Res; 2021 May; 53():102330. PubMed ID: 33857831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype and Ocular Phenotype in Sixteen Chinese Patients with Bietti Corneoretinal Crystalline Dystrophy.
    Dai H; Zhang Y; Li R; Li Y; Li G
    Curr Eye Res; 2022 Mar; 47(3):436-442. PubMed ID: 34724870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy.
    Lin J; Nishiguchi KM; Nakamura M; Dryja TP; Berson EL; Miyake Y
    J Med Genet; 2005 Jun; 42(6):e38. PubMed ID: 15937078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Bietti Crystalline Dystrophy.
    Ng DS; Lai TY; Ng TK; Pang CP
    Asia Pac J Ophthalmol (Phila); 2016; 5(4):245-52. PubMed ID: 27228076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bietti Crystalline Dystrophy Mouse Model Shows Increased Sensitivity to Light-Induced Injury.
    Ma Z; Jiao X; Agbaga MP; Anderson RE; Qian H; Li Q; Dong L; Hejtmancik JF
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal deposits on the lens capsules in Bietti crystalline corneoretinal dystrophy associated with a mutation in the CYP4V2 gene.
    Yokoi Y; Nakazawa M; Mizukoshi S; Sato K; Usui T; Takeuchi K
    Acta Ophthalmol; 2010 Aug; 88(5):607-9. PubMed ID: 19508456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular findings in three Lebanese families with Bietti crystalline dystrophy: report on a novel mutation.
    Haddad NM; Waked N; Bejjani R; Khoueir Z; Chouery E; Corbani S; Mégarbané A
    Mol Vis; 2012; 18():1182-8. PubMed ID: 22605929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal characterisation of function and structure of Bietti crystalline dystrophy: report on a novel homozygous mutation in
    Lockhart CM; Smith TB; Yang P; Naidu M; Rettie AE; Nath A; Weleber R; Kelly EJ
    Br J Ophthalmol; 2018 Feb; 102(2):187-194. PubMed ID: 28698241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New compound heterozygous CYP4V2 mutations in bietti crystalline corneoretinal dystrophy.
    Wang T; Chen Q; Yao X; Kuang L; Gan R; Wang J; Yan X
    Gene; 2021 Jul; 790():145698. PubMed ID: 33964374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.